Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

SELL
$46.53 - $55.17 $495,870 - $587,946
-10,657 Reduced 25.3%
31,459 $1.65 Million
Q1 2022

Apr 27, 2022

SELL
$45.75 - $56.69 $176,137 - $218,256
-3,850 Reduced 8.38%
42,116 $2.18 Million
Q4 2021

Jan 20, 2022

BUY
$41.32 - $61.25 $51,939 - $76,991
1,257 Added 2.81%
45,966 $2.71 Million
Q3 2021

Oct 15, 2021

SELL
$39.25 - $50.42 $50,279 - $64,588
-1,281 Reduced 2.79%
44,709 $1.92 Million
Q2 2021

Jul 14, 2021

SELL
$35.91 - $40.68 $102,163 - $115,734
-2,845 Reduced 5.83%
45,990 $1.8 Million
Q1 2021

Apr 20, 2021

SELL
$33.49 - $37.77 $197,724 - $222,994
-5,904 Reduced 10.79%
48,835 $1.77 Million
Q4 2020

Jan 29, 2021

BUY
$33.47 - $42.56 $53,217 - $67,670
1,590 Added 2.99%
54,739 $2.02 Million
Q3 2020

Oct 15, 2020

SELL
$31.75 - $37.25 $706,755 - $829,185
-22,260 Reduced 29.52%
53,149 $1.95 Million
Q2 2020

Jul 14, 2020

BUY
$30.12 - $36.54 $453,456 - $550,109
15,055 Added 24.94%
75,409 $2.47 Million
Q1 2020

Apr 23, 2020

BUY
$27.03 - $38.62 $479,377 - $684,925
17,735 Added 41.61%
60,354 $1.97 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $500,351 - $567,834
-15,199 Reduced 26.29%
42,619 $1.67 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $777,193 - $1.01 Million
23,921 Added 70.57%
57,818 $2.08 Million
Q2 2019

Aug 09, 2019

BUY
$36.98 - $41.52 $25,516 - $28,648
690 Added 2.08%
33,897 $1.47 Million
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $81,825 - $89,898
2,182 Added 7.03%
33,207 $1.41 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $1.19 Million - $1.36 Million
31,025 New
31,025 $1.35 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Fortem Financial Group, LLC Portfolio

Follow Fortem Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortem Financial Group, LLC with notifications on news.